What is the brand name of Rilpivirine?

Rilpivirine is an antiretroviral medication commonly used in the treatment of HIV. Its brand name, Edurant, is well recognized in both clinical and patient settings. This medication functions as a non-nucleoside reverse transcriptase inhibitor (NNRTI), which means it interferes with the HIV virus's ability to replicate by blocking its reverse transcriptase enzyme.

The other choices represent different antiretroviral drugs. Viramune is the brand name for Nevirapine, which is also an NNRTI but differs from Rilpivirine in its formulation and specific use cases. Sustiva is the brand name for Efavirenz, another NNRTI but with a distinct mechanism and side effect profile compared to Rilpivirine. Pifeltro, on the other hand, is the brand name for Doravirine, which is a newer NNRTI that also acts differently and is used for specific patient populations.

Thus, Edurant is specifically associated with Rilpivirine and is the correct answer to the question. Understanding the distinctions between these medications is important for anyone studying pharmacology or treating HIV, as it influences treatment decision-making.